scispace - formally typeset
M

Mick van de Wiel

Researcher at University of Antwerp

Publications -  5
Citations -  122

Mick van de Wiel is an academic researcher from University of Antwerp. The author has contributed to research in topics: Internal medicine & Disease. The author has an hindex of 3, co-authored 3 publications receiving 95 citations.

Papers
More filters
Journal ArticleDOI

Neoadjuvant systemic therapy in breast cancer: Challenges and uncertainties.

TL;DR: In this paper, the authors discuss the questions why, when and which regimen to use for patients with locally advanced breast cancer (LABC) with the introduction of the platina derivatives in neoadjuvant trials.
Journal ArticleDOI

Incorporating anti-VEGF pathway therapy as a continuum of care in metastatic colorectal cancer.

TL;DR: Bvacizumab should be included in upfront treatment regimens for all mCRC patients independently of RAS status, unless contraindicated, and anti-VEGF treatment has a well-documented role in this approach.
Journal ArticleDOI

Communication skills training in advance care planning: a survey among medical students at the University of Antwerp

TL;DR: In this paper , a survey compromising a custom-built PC knowledge test and a self-confidence assessment of communicative skills used in end-of-life conversations was conducted with two cohorts of second master's year MD students at the University of Antwerp.
Journal ArticleDOI

New Implications of Patients’ Sex in Today’s Lung Cancer Management

TL;DR: It is concluded that sex is an important but often overlooked factor in modern-day thoracic oncology practice and women should be specifically targeted in smoking cessation campaigns and sex-specific barriers should be addressed.